$MANH
MANHATTAN ASSOCIATES INC

2024 Q3 Form 10-Q Financial Statement

#000095017024086805 Filed on July 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $266.7M $265.3M
YoY Change 11.84% 14.85%
Cost Of Revenue $118.7M $120.0M
YoY Change 6.48% 10.32%
Gross Profit $148.0M $145.3M
YoY Change 16.55% 18.88%
Gross Profit Margin 55.5% 54.76%
Selling, General & Admin $36.89M $40.27M
YoY Change -5.45% 3.78%
% of Gross Profit 24.92% 27.72%
Research & Development $34.35M $35.33M
YoY Change 3.8% 11.82%
% of Gross Profit 23.21% 24.32%
Depreciation & Amortization $1.688M $1.489M
YoY Change 20.57% 12.8%
% of Gross Profit 1.14% 1.02%
Operating Expenses $72.93M $77.09M
YoY Change 1.13% 7.49%
Operating Profit $75.09M $68.19M
YoY Change 40.49% 35.07%
Interest Expense $300.0K $600.0K
YoY Change -175.0% 20.0%
% of Operating Profit 0.4% 0.88%
Other Income/Expense, Net $1.312M $914.0K
YoY Change -24.55% 68.95%
Pretax Income $76.40M $69.10M
YoY Change 38.44% 34.12%
Income Tax $12.62M $16.34M
% Of Pretax Income 16.52% 23.64%
Net Earnings $63.78M $52.77M
YoY Change 29.06% 33.18%
Net Earnings / Revenue 23.92% 19.89%
Basic Earnings Per Share $1.04 $0.86
Diluted Earnings Per Share $1.03 $0.85
COMMON SHARES
Basic Shares Outstanding 61.25M 61.57M
Diluted Shares Outstanding 61.95M 62.12M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $215.0M $202.7M
YoY Change 17.91% 32.24%
Cash & Equivalents $215.0M $202.7M
Short-Term Investments
Other Short-Term Assets $37.61M $32.21M
YoY Change 38.25% 13.93%
Inventory
Prepaid Expenses
Receivables $199.8M $191.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $452.3M $426.1M
YoY Change 15.13% 18.37%
LONG-TERM ASSETS
Property, Plant & Equipment $62.90M $64.57M
YoY Change 458.34% 132.23%
Goodwill $62.24M $62.23M
YoY Change 0.01% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $120.7M $112.4M
YoY Change 287.53% 46.05%
Total Long-Term Assets $245.8M $239.2M
YoY Change 36.47% 43.23%
TOTAL ASSETS
Total Short-Term Assets $452.3M $426.1M
Total Long-Term Assets $245.8M $239.2M
Total Assets $698.1M $665.3M
YoY Change 21.84% 26.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.18M $25.58M
YoY Change -8.2% -2.08%
Accrued Expenses $86.24M $77.72M
YoY Change -7.87% 0.57%
Deferred Revenue $252.5M $259.0M
YoY Change 18.32% 14.04%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $362.2M $362.7M
YoY Change 8.84% 9.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $57.95M $61.97M
YoY Change 319.08% 139.88%
Total Long-Term Liabilities $57.95M $61.97M
YoY Change 319.08% 139.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $362.2M $362.7M
Total Long-Term Liabilities $57.95M $61.97M
Total Liabilities $420.2M $424.7M
YoY Change 21.21% 19.14%
SHAREHOLDERS EQUITY
Retained Earnings $303.4M $267.8M
YoY Change 27.29% 36.15%
Common Stock $610.0K $612.0K
YoY Change -0.97% -0.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $278.0M $240.6M
YoY Change
Total Liabilities & Shareholders Equity $698.1M $665.3M
YoY Change 21.84% 26.25%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $63.78M $52.77M
YoY Change 29.06% 33.18%
Depreciation, Depletion And Amortization $1.688M $1.489M
YoY Change 20.57% 12.8%
Cash From Operating Activities $62.30M $73.26M
YoY Change 6.31% 80.58%
INVESTING ACTIVITIES
Capital Expenditures $1.009M $2.217M
YoY Change -8.27% 119.72%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.009M -$2.217M
YoY Change -8.27% 119.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -51.60M -75.71M
YoY Change 94.0% 12.29%
NET CHANGE
Cash From Operating Activities 62.30M 73.26M
Cash From Investing Activities -1.009M -2.217M
Cash From Financing Activities -51.60M -75.71M
Net Change In Cash 9.686M -4.667M
YoY Change -68.65% -83.25%
FREE CASH FLOW
Cash From Operating Activities $62.30M $73.26M
Capital Expenditures $1.009M $2.217M
Free Cash Flow $61.29M $71.05M
YoY Change 6.59% 79.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001056696
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-23999
dei Entity Registrant Name
EntityRegistrantName
MANHATTAN ASSOCIATES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
58-2373424
dei Entity Address Address Line1
EntityAddressAddressLine1
2300 Windy Ridge Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Tenth Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
955-7070
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
MANH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61245946
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202709000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
270741000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
191226000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
181173000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32211000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27276000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
426146000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
479190000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13392000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11795000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51181000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21645000
CY2024Q2 us-gaap Goodwill
Goodwill
62230000
CY2023Q4 us-gaap Goodwill
Goodwill
62235000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
78529000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
66043000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
33834000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32445000
CY2024Q2 us-gaap Assets
Assets
665312000
CY2023Q4 us-gaap Assets
Assets
673353000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
25581000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24508000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54550000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
73210000
CY2024Q2 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
23167000
CY2023Q4 manh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
27374000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
258987000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
237793000
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
425000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3030000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
362710000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
365915000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50842000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17694000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11131000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11466000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61245638
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61245638
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61566037
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61566037
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
612000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
615000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
267771000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
304701000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27754000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27038000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
240629000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278278000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
665312000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
673353000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
265318000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231016000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
519870000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
452029000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35334000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31600000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70344000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62394000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19154000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18563000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
39083000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36628000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21112000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20237000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42315000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40190000
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1489000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1320000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2982000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2807000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
197130000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
180533000
us-gaap Costs And Expenses
CostsAndExpenses
394052000
us-gaap Costs And Expenses
CostsAndExpenses
354461000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
68188000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
50483000
us-gaap Operating Income Loss
OperatingIncomeLoss
125818000
us-gaap Operating Income Loss
OperatingIncomeLoss
97568000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
914000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1041000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1910000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1184000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69102000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
51524000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
127728000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
98752000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16336000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11904000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21161000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20341000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
52766000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
39620000
us-gaap Net Income Loss
NetIncomeLoss
106567000
us-gaap Net Income Loss
NetIncomeLoss
78411000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.25
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61421000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61862000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61523000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62036000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62118000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62432000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62305000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62599000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
52766000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
39620000
us-gaap Net Income Loss
NetIncomeLoss
106567000
us-gaap Net Income Loss
NetIncomeLoss
78411000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-716000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
792000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52777000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39604000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
105851000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79203000
us-gaap Profit Loss
ProfitLoss
106567000
us-gaap Profit Loss
ProfitLoss
78411000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2982000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2807000
us-gaap Share Based Compensation
ShareBasedCompensation
46761000
us-gaap Share Based Compensation
ShareBasedCompensation
34568000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
124000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-22000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-12519000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-11038000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-610000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1577000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11153000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11024000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2088000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5825000
manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
-18082000
manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
-2593000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7043000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-5359000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
22089000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
17740000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
128000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
99286000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4538000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1675000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4538000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1675000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
189546000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
169115000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-189546000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-169115000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1948000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-665000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-68032000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-72169000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
270741000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
225463000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
202709000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
153294000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
239607000
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75712000
CY2024Q2 manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
709000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
24666000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
52766000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
240629000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278278000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
189546000
manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
715000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
46761000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-716000
us-gaap Net Income Loss
NetIncomeLoss
106567000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
240629000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
181072000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
67427000
CY2023Q2 manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
627000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
17928000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
39620000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
170550000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
226800000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
169115000
manh Excise Tax On Net Stock Repurchases
ExciseTaxOnNetStockRepurchases
906000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
34568000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
792000
us-gaap Net Income Loss
NetIncomeLoss
78411000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
170550000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1600000000
us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
We expect to recognize revenue on approximately 40% of these remaining performance obligations over the next 24 months with the majority of the remaining balance recognized over the following 36 months.
manh Expected Percentage Of Revenue Recognized From Remaining Performance Obligation Over Twenty Four Months
ExpectedPercentageOfRevenueRecognizedFromRemainingPerformanceObligationOverTwentyFourMonths
0.40
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
900000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
900000
CY2024Q2 manh Other Provisions For Doubtful Accounts Valuation Allowance
OtherProvisionsForDoubtfulAccountsValuationAllowance
3700000
CY2023Q4 manh Other Provisions For Doubtful Accounts Valuation Allowance
OtherProvisionsForDoubtfulAccountsValuationAllowance
4400000
us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
We apply the practical expedient to expense sales commissions when the amortization period would have been one year or less.
CY2024Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2600000
CY2023Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2300000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
5300000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
4600000
CY2023Q2 us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
CY2024Q2 us-gaap Deferred Sales Inducement Cost Impairment Loss
DeferredSalesInducementCostImpairmentLoss
0
CY2024Q2 us-gaap Cash
Cash
106700000
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
96000000
CY2024Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
24700000
CY2023Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
17900000
us-gaap Restricted Stock Expense
RestrictedStockExpense
46800000
us-gaap Restricted Stock Expense
RestrictedStockExpense
34600000
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.166
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.206
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
52766000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
39620000
us-gaap Net Income Loss
NetIncomeLoss
106567000
us-gaap Net Income Loss
NetIncomeLoss
78411000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2024Q2 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.01
CY2023Q2 manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.01
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.02
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.01
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.25
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61421000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61862000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61523000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62036000
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
697000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
570000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
782000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
563000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62118000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62432000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62305000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62599000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
265318000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231016000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
120041000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108813000
CY2024Q2 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
75600000
CY2023Q2 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
70400000
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1489000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1320000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
197130000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
180533000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
68188000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
50483000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
519870000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
452029000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
239328000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
212442000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
151742000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
139212000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2982000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2807000
us-gaap Costs And Expenses
CostsAndExpenses
394052000
us-gaap Costs And Expenses
CostsAndExpenses
354461000
us-gaap Operating Income Loss
OperatingIncomeLoss
125818000
us-gaap Operating Income Loss
OperatingIncomeLoss
97568000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-086805-index-headers.html Edgar Link pending
0000950170-24-086805-index.html Edgar Link pending
0000950170-24-086805.txt Edgar Link pending
0000950170-24-086805-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
manh-20240630.htm Edgar Link pending
manh-20240630.xsd Edgar Link pending
manh-ex31_1.htm Edgar Link pending
manh-ex31_2.htm Edgar Link pending
manh-ex32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
manh-20240630_htm.xml Edgar Link completed